Nong S - Search Results

1

β-elemene induced anticancer effect in bladder cancer through upregulation of PTEN and suppression of AKT phosphorylation.

Cai B, Ma L, Nong S, Wu Y, Guo X, Pu J. Cai B, et al. Among authors: nong s. Oncol Lett. 2018 Nov;16(5):6019-6025. doi: 10.3892/ol.2018.9401. Epub 2018 Sep 5. Oncol Lett. 2018. PMID: 30333873 Free PMC article.

2

[Predictive factors for clinically significant elevation of post-prostatectomy Gleason score in patients with biopsy Gleason score ≤7].

Guo X, Ma LM, Wu Y, Zhang YP, Li HL, Nong SJ, Guan YB, Huang YQ, Cai B. Guo X, et al. Zhonghua Nan Ke Xue. 2018 Dec;24(12):1094-1099. Zhonghua Nan Ke Xue. 2018. PMID: 32212489 Chinese.

3

HN1L promotes stem cell-like properties by regulating TGF-β signaling pathway through targeting FOXP2 in prostate cancer.

Nong S, Wang Z, Wei Z, Ma L, Guan Y, Ni J. Nong S, et al. Cell Biol Int. 2022 Jan;46(1):83-95. doi: 10.1002/cbin.11701. Epub 2021 Oct 5. Cell Biol Int. 2022. PMID: 34519127

4

Reduced DAPK1 Expression Promotes Stem Cell-Like Characteristics of Prostate Cancer Cells by Activating ZEB1 via Hippo/YAP Signaling Pathway.

Nong S, Wei Z, Wang Z, Ma L, Guan Y, Ni J. Nong S, et al. Stem Cells Dev. 2021 Sep 15;30(18):934-945. doi: 10.1089/scd.2021.0043. Epub 2021 Aug 17. Stem Cells Dev. 2021. PMID: 34289746

5

Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.

Guan Y, Wu Y, Liu Y, Ni J, Nong S. Guan Y, et al. Among authors: nong s. Prostate. 2016 Aug;76(11):986-93. doi: 10.1002/pros.23187. Epub 2016 Apr 4. Prostate. 2016. PMID: 27040772

6

Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy.

Xiao Y, Dong Y, Yu T, Wang R, Gao Y, Li S, Nong S, Li W. Xiao Y, et al. Among authors: nong s. Front Immunol. 2022 Aug 26;13:941189. doi: 10.3389/fimmu.2022.941189. eCollection 2022. Front Immunol. 2022. PMID: 36091015 Free PMC article.

7

Two novel hydroperoxylated products of 20(S)-protopanaxadiol produced by Mucor racemosus and their cytotoxic activities against human prostate cancer cells.

Chen G, Yang X, Nong S, Yang M, Xu B, Zhang W. Chen G, et al. Among authors: nong s. Biotechnol Lett. 2013 Mar;35(3):439-43. doi: 10.1007/s10529-012-1098-x. Epub 2012 Nov 27. Biotechnol Lett. 2013. PMID: 23183919

8

Breviscapine (BVP) inhibits prostate cancer progression through damaging DNA by minichromosome maintenance protein-7 (MCM-7) modulation.

Guan YB, Yang DR, Nong SJ, Ni J, Hu CH, Li J, Zhu J, Shan YX. Guan YB, et al. Biomed Pharmacother. 2017 Sep;93:103-116. doi: 10.1016/j.biopha.2017.06.024. Epub 2017 Jun 17. Biomed Pharmacother. 2017. PMID: 28628830

9

[Adenovirus-mediated combined gene therapy of interleukin-18 and interleukin-12 for prostate cancer: an experimental study].

Cheng B, Nong SJ, Zhang YP. Cheng B, et al. Zhonghua Yi Xue Za Zhi. 2013 May 28;93(20):1590-3. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24028732 Chinese.

10

Microbial transformation of 20(S)-protopanaxadiol by Absidia corymbifera. Cytotoxic activity of the metabolites against human prostate cancer cells.

Chen G, Yang M, Nong S, Yang X, Ling Y, Wang D, Wang X, Zhang W. Chen G, et al. Among authors: nong s. Fitoterapia. 2013 Jan;84:6-10. doi: 10.1016/j.fitote.2012.09.018. Epub 2012 Sep 28. Fitoterapia. 2013. PMID: 23022533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters